➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Merck
Boehringer Ingelheim
McKinsey

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories (S.D. Cal. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories (S.D. Cal. 2017)

Docket   Start Trial Date Filed 2017-09-05
Court District Court, S.D. California Date Terminated
Cause 35:0271 Patent Infringement Assigned To Marco A. Hernandez
Jury Demand Both Referred To
Parties COLUMBIA SPORTSWEAR NORTH AMERICA, INC.; SEIRUS INNOVATIVE ACCESSORIES
Patents 6,020,001
Attorneys Alison A. Grounds; Anup M. Shah; Brenna K. Legaard; Brian Jeffrey Nese; Christopher S. Marchese; Christopher Scott Marchese; David Robert Boyajian; David W. Axelrod; Devon Zastrow Newman; Eric M. Jaegers; Garrett K Sakimae; Jasmine C. Hites; Lisa D. Hardie; Matthew D. Murphey; Nicholas F. Aldrich , Jr.; Paul E McGowan; Renee E. Rothauge; Seth M Sproul; Tucker N. Terhufen
Firms Eric M. Jaegers; Fish & Richardson PC; Markowitz, Herbold, Glade and Mehlhaf; Schwabe, Williamson & Wyatt; Schwabe, Williamson & Wyatt, P.C.; Stoel Rives LLP; Troutman Sanders LLC; Troutman Sanders LLP; Troutman Sanders, LLP; US Patent & Trademark Office
Link to Docket External link to docket
Small Molecule Drugs cited in Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories (S.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-11-16 393 Memo of Points and Authorities Document 393-1 Filed 11/16/17 PageID.18164 Page 6 of 20 1 Western Systems, Inc. v Ulloa, 2 958 …Inc. (“Seirus”) asserting three 5 patents. One of those patents—D657,093—has become known in this case…the U.S. Patent and Trademark Office (“PTO”) to challenge the validity of the Design 17 Patent. The sole…increases the efficiency of patent litigation” and ignoring “a consent decree [on patent 7 validity] constitutes…judgment on patent validity, “[t]o allow [defendants] to 14 request reexamination of patent claims which External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Moodys
McKesson
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.